Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin

Alok Pant, Irene I. Lee, Zhenxiao Lu, Bo R. Rueda, Julian Schink, J. Julie Kim

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Fingerprint Dive into the research topics of 'Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds

Agriculture & Biology